Cargando…
ARF6 is a host factor for SARS-CoV-2 infection in vitro
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged beta-coronavirus that enter cells via two routes, direct fusion at the plasma membrane or endocytosis followed by fusion with the late endosome/lysosome. While the viral receptor, ACE2, multiple entry factors and the mec...
Autores principales: | Mirabelli, C., Bragazzi Cunha, J., Wotring, J. W., Sherman, E. J., El Saghir, J., Harder, J., Kretzler, M., Sexton, J. Z., Emmer, B. T., Wobus, C. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397720/ https://www.ncbi.nlm.nih.gov/pubmed/37342971 http://dx.doi.org/10.1099/jgv.0.001868 |
Ejemplares similares
-
Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection
por: Cunha, Juliana Bragazzi, et al.
Publicado: (2023) -
In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
por: Wotring, Jesse W., et al.
Publicado: (2022) -
In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
por: Wotring, Jesse W., et al.
Publicado: (2022) -
Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
por: Davies, Katherine, et al.
Publicado: (2021) -
Identification of cell type specific ACE2 modifiers by CRISPR screening
por: Sherman, Emily J., et al.
Publicado: (2022)